Patient Education - Endocrine Encyclopedia
Endocrine Surgery Encyclopedia
Definition:
Medullary carcinoma of the thyroid is a malignancy of the thyroid gland arising from
the C cell, which secretes the hormone calcitonin.
Alternative Names: Thyroid - medullary carcinoma; Cancer - thyroid (medullary
carcinoma)
Causes, incidence, and risk factors:
The cause is unknown, but is not thought to be related to radiation therapy, as opposed
to other thyroid cancers. Thyroid function tests are usually normal. Risk factors
are a family history of multiple endocrine neoplasia (MEN), a prior history of pheochromocytoma,
mucosal neuromas, or hyperparathyroidism.
The average age at diagnosis is the mid-40s, except in patients with inherited
cancer syndromes, in which the cancer often occurs earlier. Approximately 700 new
cases are diagnosed each year in the United States. The condition runs in the family
about 20% of the time.
Other types of thyroid cancer are papillary carcinoma of the thyroid, anaplastic
carcinoma of the thyroid, follicular tumor of the thyroid, thyroid lymphoma, and
metastatic thyroid cancer.
Symptoms:
- Firm thyroid mass
- Goiter
- Diarrhea
- Cough
- Cough with blood
Signs and tests:
-
A physical examination reveals enlarged cervical lymph nodes.
- An examination of the thyroid reveals single or multiple nodules.
- A thyroid biopsy shows medullary carcinoma of thyroid cells.
- An ultrasound of the thyroid reveals a nodule.
- A thyroid scan shows a cold nodule (one that does not light up on scan).
- The calcitonin level is elevated.
Treatment:
Surgical removal of the thyroid gland, as well as surrounding lymph nodes, is the
initial treatment. Chemotherapy and radiation are not very effective.
The risks of surgery include accidental removal of parathyroid glands or nerve
tissue of the larynx, which leads to serious complications.
Support Groups:
For additional resources, see cancer support group.
Expectations (prognosis):
The expectation for this type of thyroid cancer varies, depending on the removal
of all cancerous tissue. The 10-year survival rate (percentage of people who live
at least 10 years after diagnosis) is 70 - 80%.
Complications:
- Medullary carcinoma invading nearby lymph nodes
- Inadvertent removal of parathyroid glands during surgery
- Metastasis of cancer to blood vessels or other sites
Calling your health care provider:
Call for an appointment with your health care provider if symptoms of this disorder
develop.
Prevention:
Prevention may not be possible. However, being aware of your risk factors, especially
a family history, may allow early diagnosis and treatment.
Review Date: 11/9/2004
Reviewed By: Marcia S. Brose, M.D., Ph.D., Assistant Professor, Hematology/Oncology,
The University of Pennsylvania Cancer Center, Philadelphia, PA. Review provided by
VeriMed Healthcare Network.
 A.D.A.M.,
Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission
(www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M.
follows rigorous standards of quality and accountability. A.D.A.M. is among the first to
achieve this important distinction for online health information and services. Learn more
about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also
a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net
Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for
the diagnosis or treatment of any medical condition. A licensed medical professional should
be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for
all medical emergencies. Links to other sites are provided for information only -- they do
not constitute endorsements of those other sites. © 1997- 2007 A.D.A.M., Inc. Any duplication
or distribution of the information contained herein is strictly prohibited.
|
